Clinical Trial Update: Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 study of Nitrocamptothecin in glioblastoma multiforme has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Nitrocamptothecin (nitrocamptothecin)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED